Click a link below to view the mailing archive as if it had been sent to you.
| 2019-09-30 12:15 | | Report: Medtronic establishes $35m settlement fund for Synchromed pumps and more... |
| 2019-09-30 00:15 | | ESMO: Merck, Eisai detail Keytruda-Lenvima combo results after triple endometrial cancer OK and more... |
| 2019-09-29 12:15 | | Separate GSK, AstraZeneca trial results may widen ovarian cancer drug use |
| 2019-09-29 00:15 | | Mylan Stock Dives On $30 Million Settlement In EpiPen Scandal and more... |
| 2019-09-27 12:15 | | Shiny, new and expensive: ESMO studies find new cancer drugs carry higher prices, add little benefit and more... |
| 2019-09-27 00:15 | | Pfizer buys Durham facility as expansion plans continue to unfold and more... |
| 2019-09-26 12:15 | | Enanta's NASH drug barely meets main goal in mid-stage study and more... |
| 2019-09-26 00:15 | | Deep Genomics reveals its program: The first AI-discovered drug candidate and more... |
| 2019-09-25 12:15 | | Roche-Spark deal review in U.K. unnerves M&A watchers—and they were spooked already and more... |
| 2019-09-25 00:15 | | Novartis to put AveXis into protective custody after data manipulation scandal and more... |
| 2019-09-24 12:15 | | GW Pharma's cannabis-derived epilepsy medicine makes the cut in the European Union and more... |
| 2019-09-24 00:15 | | Cancer centers stretching to keep up with pharma's oncology interest and more... |
| 2019-09-23 12:15 | | AbbVie's premium bid for Allergan isn't enough for one investor, who's suing to block it and more... |
| 2019-09-23 00:15 | | The Week Ahead In Biotech: Spotlight On ESMO Conference and more... |
| 2019-09-22 00:15 | | Can Synthetic Biology Make Insulin Faster, Better and Cheaper? and more... |
| 2019-09-21 00:15 | | The top drugs facing cuts under Pelosi's pricing plan and more... |
| 2019-09-20 12:15 | | Genentech submits a plan to nearly double its South San Francisco footprint and more... |
| 2019-09-20 00:15 | | Regulatory barriers limit state alternative Rx payment models and more... |
| 2019-09-19 12:15 | | Employers Slowly Warm to Point-of-Sale Rebates—But Must Move Faster for Insulin and more... |
| 2019-09-19 00:15 | | Evidence underpinning approval of new cancer drugs raises questions and more... |
| 2019-09-18 12:15 | | Could Amgen's Latest Bad News Boost the Chances of More Acquisitions? and more... |
| 2019-09-18 00:15 | | EASD: Novo's Ozempic tops Victoza, J&J's Invokana in double head-to-head win and more... |
| 2019-09-17 12:15 | | EASD: Lilly, BI tout new Jardiance kidney analysis as rival J&J nears FDA nod and more... |
| 2019-09-17 00:15 | | Biden Praises Pharma to Donors as He Pushes to Cut Prices and more... |
| 2019-09-16 12:15 | | Purdue Pharma, maker of OxyContin and other drugs, files for bankruptcy and more... |
| 2019-09-16 00:15 | | The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck and more... |
| 2019-09-14 12:15 | | Early snapshot of Adverum's eye gene therapy sparks concern about vision loss and more... |
| 2019-09-14 00:15 | | Aimmune's peanut allergy drug secures FDA panel support, along with criticism and more... |
| 2019-09-13 12:15 | | Amgen shares hit after analysts expose buried FDA trial halt and more... |
| 2019-09-13 00:15 | | Aspen's drug to prevent preterm birth approved by FDA and more... |
| 2019-09-12 12:15 | | Pfizer hires ex-FDA, MD Anderson researcher as clinical oncology lead and more... |
| 2019-09-12 00:15 | | Purdue inks multibillion-dollar opioid deal with thousands of local governments, 23 states: reports and more... |
| 2019-09-11 12:15 | | Promising autoimmune biotech gets $40 million as celiac drug is pushed to clinic and more... |
| 2019-09-11 00:15 | | Esmo 2019 preview – immunotherapies grab the rest of the late-breaker focus and more... |
| 2019-09-10 12:15 | | Drug Prices Keep Rising Amid Political Pressure, But Not As Fast and more... |
| 2019-09-10 00:15 | | Novartis backs brolucizumab with new head-to-head Eylea trial and more... |
| 2019-09-09 12:15 | | Novartis Makes New Data Integrity Commitment and more... |
| 2019-09-08 00:15 | | What could help biotech close out 2019 stronger? Analysts pick 3 events to watch and more... |
| 2019-09-07 00:15 | | Takeda recalls Natpara but warns patients not to abruptly stop treatment and more... |
| 2019-09-06 12:15 | | Stephen Hahn, 'clear frontrunner' for FDA commish job, has met with Trump — reports and more... |
| 2019-09-06 00:15 | | 4 Biotech Stocks With Big Catalysts in September and more... |
| 2019-09-05 12:15 | | Amgen's Aimovig, under fire from Lilly, loses grip on CGRP share and more... |
| 2019-09-05 00:15 | | The pharma industry's rep hits absolute. rock. bottom. and more... |
| 2019-09-04 12:15 | | New Sanofi CEO Paul Hudson embarks on fact-finding journey. What's his next move? and more... |
| 2019-09-04 00:15 | | With bellwether opioid trial nearing, Ohio AG pushes for delay and more... |
| 2019-09-03 12:15 | | As Genfit hopes to get its liver drug on the market, founding CEO makes way for new blood and more... |
| 2019-09-03 00:15 | | MedCo's PCSK9 challenger steals the show at ESC with winning data and more... |
| 2019-09-01 00:15 | | Early Focus On Surgical Robotics Gives Stryker A Leg Up and more... |
